https://www.novumpr.nl/2019/10/31/vertex-announces-european-medicines-agency-marketing-authorization-application-validation-for-vx-445-elexacaftor-tezacaftor-and-ivacaftor-triple-combination-treatment-in-cystic-fibrosis/?utm_source=rss&utm_medium=rss&utm_campaign=vertex-announces-european-medicines-agency-marketing-authorization-application-validation-for-vx-445-elexacaftor-tezacaftor-and-ivacaftor-triple-combination-treatment-in-cystic-fibrosis NovumPR press releases Thu, 31 Oct 2019 11:29:32 +0000 hourly 1 https://wordpress.org/?v=6.8.3